Yuwei Tian

1.1k total citations
37 papers, 931 citations indexed

About

Yuwei Tian is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Yuwei Tian has authored 37 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Yuwei Tian's work include Mass Spectrometry Techniques and Applications (7 papers), Protein purification and stability (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Yuwei Tian is often cited by papers focused on Mass Spectrometry Techniques and Applications (7 papers), Protein purification and stability (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Yuwei Tian collaborates with scholars based in China, United States and France. Yuwei Tian's co-authors include Brandon T. Ruotolo, Linjie Han, Joseph D. Eschweiler, Jessica N. Rabuck-Gibbons, Jie Dou, Changlin Zhou, Huanzhou Xue, Quan Shen, Qingfeng Jiang and Hui Wang and has published in prestigious journals such as Biomaterials, Analytical Chemistry and Cancer Research.

In The Last Decade

Yuwei Tian

34 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuwei Tian China 20 608 312 163 119 119 37 931
Petr Pompach Czechia 22 945 1.6× 341 1.1× 132 0.8× 37 0.3× 207 1.7× 60 1.3k
Hermann Beck Germany 11 766 1.3× 180 0.6× 431 2.6× 85 0.7× 246 2.1× 16 1.0k
Shujia Dai United States 18 689 1.1× 289 0.9× 137 0.8× 19 0.2× 186 1.6× 29 1.1k
Sheng Gu United States 18 935 1.5× 319 1.0× 147 0.9× 21 0.2× 160 1.3× 25 1.2k
Koji Nishi Japan 20 577 0.9× 80 0.3× 94 0.6× 103 0.9× 128 1.1× 89 1.2k
Bao‐Shiang Lee United States 17 498 0.8× 102 0.3× 136 0.8× 45 0.4× 94 0.8× 46 868
Christopher J. Hipolito Japan 16 1.2k 1.9× 143 0.5× 111 0.7× 38 0.3× 47 0.4× 29 1.5k
Henrik Rahbek-Nielsen Denmark 13 537 0.9× 290 0.9× 70 0.4× 14 0.1× 99 0.8× 14 1.0k
Gerald Stübiger Austria 19 618 1.0× 300 1.0× 22 0.1× 112 0.9× 56 0.5× 27 983
Weixuan Chen United States 17 627 1.0× 297 1.0× 108 0.7× 19 0.2× 38 0.3× 36 931

Countries citing papers authored by Yuwei Tian

Since Specialization
Citations

This map shows the geographic impact of Yuwei Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwei Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwei Tian more than expected).

Fields of papers citing papers by Yuwei Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwei Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwei Tian. The network helps show where Yuwei Tian may publish in the future.

Co-authorship network of co-authors of Yuwei Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwei Tian. A scholar is included among the top collaborators of Yuwei Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwei Tian. Yuwei Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Weijie, et al.. (2025). Alterations of White Matter Microstructure in Primary Aldosteronism Patients With Normal Cognitive Functioning Using Diffusion Tensor Imaging. International Journal of General Medicine. Volume 18. 1089–1102.
2.
Lodge, Jean M., et al.. (2024). Native Digestion and Shotgun Proteomics for Host Cell Protein Profiling of Adeno-Associated Viruses. Analytical Chemistry. 96(42). 16510–16513. 1 indexed citations
3.
Zhang, Limin, Yuwei Tian, Mengzhen Li, et al.. (2022). Peptide nano ‘bead-grafting’ for SDT-facilitated immune checkpoints blocking. Chemical Science. 13(47). 14052–14062. 19 indexed citations
4.
Tian, Yuwei, Limin Zhang, Minxuan Wang, et al.. (2021). Multi-stage responsive peptide nanosensor: Anchoring EMT and mitochondria with enhanced fluorescence and boosting tumor apoptosis. Biosensors and Bioelectronics. 184. 113235–113235. 13 indexed citations
5.
Wang, Ning, et al.. (2021). Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography–Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. Journal of the American Society for Mass Spectrometry. 32(8). 1852–1860. 16 indexed citations
6.
Jia, Xiangqian, Qiuju Han, Yuwei Tian, et al.. (2020). Synergetic Tumor Probes for Facilitating Therapeutic Delivery by Combined-Functionalized Peptide Ligands. Analytical Chemistry. 92(8). 5650–5655. 19 indexed citations
8.
Tian, Yuwei & Brandon T. Ruotolo. (2018). The growing role of structural mass spectrometry in the discovery and development of therapeutic antibodies. The Analyst. 143(11). 2459–2468. 30 indexed citations
9.
Xue, Huanzhou, et al.. (2018). Appleby operation for carcinoma of the body and tail of the pancreas. Journal of Cancer Research and Therapeutics. 14(12). 1019–1019. 3 indexed citations
11.
Tian, Yuwei, Solomon Z. Okbazghi, Rose Ackermann, et al.. (2017). A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima. Analytical Chemistry. 89(9). 4838–4846. 64 indexed citations
12.
Yu, Miao, Huanzhou Xue, Yadong Wang, et al.. (2017). miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. International Journal of Oncology. 50(3). 975–983. 65 indexed citations
13.
Ma, Lingman, Yanrong Wang, Mengxiao Wang, et al.. (2016). Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria. Biomaterials. 87. 32–45. 52 indexed citations
14.
Xue, Huanzhou, et al.. (2015). Multiple hyperplastic nodular lesions of the liver in the Budd-Chari syndrome: a case report and review of published reports. Annals of Saudi Medicine. 35(1). 72–75. 3 indexed citations
15.
Jiang, Qingfeng, Yuwei Tian, Quan Shen, Huanzhou Xue, & Ké Li. (2014). SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell. Tumor Biology. 35(10). 9677–9682. 28 indexed citations
16.
Ke, Mengyun, Hui Wang, Min Zhang, et al.. (2014). The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo. Biochemical Pharmacology. 89(1). 119–130. 30 indexed citations
17.
Wang, Hui, Mengyun Ke, Yuwei Tian, et al.. (2013). BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice. European Journal of Pharmacology. 707(1-3). 1–10. 51 indexed citations
18.
Wang, Jing, Bing Li, Li Yang, et al.. (2013). BF-30 effectively inhibits ciprofloxacin-resistant bacteria in vitro and in a rat model of vaginosis. Archives of Pharmacal Research. 37(7). 927–936. 22 indexed citations
20.
Xu, Fengguo, et al.. (2006). The pharmacokinetics of orally administered fudosteine in healthy Chinese volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 31(2). 65–71.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026